Dapoxetine works by inhibiting serotonin transporter, increasing serotonins action at the post synaptic cleft, and as a consequence promoting ejaculatory delay.
More Information Supplier PageDaphnetin is a coumarin analog that acts as an inhibitor of several protein kinases. It inhibits EGFR kinase (IC50 = 7.67 ??M), PKA (IC50 = 9.33 ??M), and PKC (IC50 = 25 ??M), in vitro. The inhibition of EGFR kinase by daphnetin was competitive to ATP and non-competitive to the peptide substrate. Also acts as […]
More Information Supplier PageDaphnetin is a coumarin analog that acts as an inhibitor of several protein kinases. It inhibits EGFR kinase (IC50 = 7.67 ??M), PKA (IC50 = 9.33 ??M), and PKC (IC50 = 25 ??M), in vitro. The inhibition of EGFR kinase by daphnetin was competitive to ATP and non-competitive to the peptide substrate. Also acts as […]
More Information Supplier PageDaphnetin is a coumarin analog that acts as an inhibitor of several protein kinases. It inhibits EGFR kinase (IC50 = 7.67 ??M), PKA (IC50 = 9.33 ??M), and PKC (IC50 = 25 ??M), in vitro. The inhibition of EGFR kinase by daphnetin was competitive to ATP and non-competitive to the peptide substrate. Also acts as […]
More Information Supplier PageDaphnetin is a coumarin analog that acts as an inhibitor of several protein kinases. It inhibits EGFR kinase (IC50 = 7.67 ??M), PKA (IC50 = 9.33 ??M), and PKC (IC50 = 25 ??M), in vitro. The inhibition of EGFR kinase by daphnetin was competitive to ATP and non-competitive to the peptide substrate. Also acts as […]
More Information Supplier PageDaphnetin is a coumarin analog that acts as an inhibitor of several protein kinases. It inhibits EGFR kinase (IC50 = 7.67 ??M), PKA (IC50 = 9.33 ??M), and PKC (IC50 = 25 ??M), in vitro. The inhibition of EGFR kinase by daphnetin was competitive to ATP and non-competitive to the peptide substrate. Also acts as […]
More Information Supplier PageDapagliflozin inhibits subtype 2 of the sodium-glucose transport proteins (SGLT2), which is responsible for at least 90% of the glucose reabsorption in the kidney.
More Information Supplier PageDapagliflozin inhibits subtype 2 of the sodium-glucose transport proteins (SGLT2), which is responsible for at least 90% of the glucose reabsorption in the kidney.
More Information Supplier PageDapagliflozin inhibits subtype 2 of the sodium-glucose transport proteins (SGLT2), which is responsible for at least 90% of the glucose reabsorption in the kidney.
More Information Supplier PageCytarabine inhibits DNA replication by incorporating into DNA (IC50 = 0.04 ??M in L1210 and CEM cell lines).
More Information Supplier Page
